Laura Bergamaschi

University of Cambridge — United Kingdom

Medicine · Health Sciences

22h-index5.1kcitations54works11.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(21), COVID-19 Clinical Research Studies(20), Long-Term Effects of COVID-19(9), Sarcoma Diagnosis and Treatment(4), Complement system in diseases(4)

Publications52 total

Disease-specific B cell clones are shared between patients with Crohn’s disease
Nature Communications·2025· 8 citedOpen Access
Corrigendum: Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs
Frontiers in Immunology·2025Open Access
Circulating Tumor DNA in Patients with Desmoid Fibromatosis during Active Surveillance
Annals of Surgical Oncology·2024
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
EBioMedicine·2024· 6 citedOpen Access
sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID
iScience·2024· 5 citedOpen Access
Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19
Nature Immunology·2024· 57 citedOpen Access
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case
Journal for ImmunoTherapy of Cancer·2024· 4 citedOpen Access
Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis
Journal of Autoimmunity·2023· 6 citedOpen Access
Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity
Cell Reports·2023· 17 citedOpen Access
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups
Frontiers in Immunology·2023· 23 citedOpen Access
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection
Nature Immunology·2023· 36 citedOpen Access
Human Cytomegalovirus Infection of Epithelial Cells Increases SARS-CoV-2 Superinfection by Upregulating the ACE2 Receptor
The Journal of Infectious Diseases·2022· 20 citedOpen Access
Proteomic analysis of circulating immune cells identifies novel cellular phenotypes associated with COVID-19 severity
2022Open Access
Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs
Frontiers in Immunology·2022· 27 citedOpen Access
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
A patient-centric modelling framework captures recovery from SARS-CoV-2 infection
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
A patient-centric modelling framework captures recovery from SARS-CoV-2 infection
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses
Brain·2022· 88 citedOpen Access
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature·2022· 3 citedOpen Access
A patient-centric characterization of systemic recovery from SARS-CoV-2 infection
2022· 2 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Paul Lyons(38), Kenneth G. C. Smith(30), John R. Bradley(25), Federica Mescia(24), Nathalie Kingston(16), Prasanti Kotagiri(15), Lorinda Turner(14), Christoph Hess(13), Ian Goodfellow(12), Paul J. Lehner(12), Nicholas J. Matheson(12), Berthold Göttgens(11), Mark Toshner(11), Anne Elmer(11), Michael P. Weekes(11), Mark R. Wills(10), Ravindra K. Gupta(10), Menna R. Clatworthy(9), Stephen Baker(9), Rainer Döffinger(9)